Live Webcast Scheduled for January 8, 2013 at 2:45 pm (PST) EMERYVILLE, Calif., Dec. 19, 2012 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that Dr. Ron Najafi, Chief Executive Officer, will present at the Biotech Showcase 2013, held January 7-9, 2013, in San Francisco, CA. Dr. Najafi will provide detail on the highlights recently announced in NovaBay's Business Update and 2013 Outlook. Dr. Najafi and Tom Paulson, Chief Financial Officer, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
|Event||Biotech Showcase 2013|
|Date||Tuesday, January 8, 2013|
|Time||2:45 pm PST|
|Place||Parc 55 Wyndham, San Francisco, CA|